ES355853A1 - Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva. - Google Patents

Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.

Info

Publication number
ES355853A1
ES355853A1 ES355853A ES355853A ES355853A1 ES 355853 A1 ES355853 A1 ES 355853A1 ES 355853 A ES355853 A ES 355853A ES 355853 A ES355853 A ES 355853A ES 355853 A1 ES355853 A1 ES 355853A1
Authority
ES
Spain
Prior art keywords
extract
acid
conjugate
pollen extract
naja
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES355853A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES355853A1 publication Critical patent/ES355853A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES355853A 1967-07-07 1968-07-06 Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva. Expired ES355853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31374/67A GB1174854A (en) 1967-07-07 1967-07-07 New Biologically Active Conjugates

Publications (1)

Publication Number Publication Date
ES355853A1 true ES355853A1 (es) 1970-03-01

Family

ID=10322153

Family Applications (1)

Application Number Title Priority Date Filing Date
ES355853A Expired ES355853A1 (es) 1967-07-07 1968-07-06 Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.

Country Status (10)

Country Link
BE (1) BE717689A (enrdf_load_html_response)
CH (1) CH526590A (enrdf_load_html_response)
DE (1) DE1768841C3 (enrdf_load_html_response)
ES (1) ES355853A1 (enrdf_load_html_response)
FR (2) FR1584763A (enrdf_load_html_response)
GB (1) GB1174854A (enrdf_load_html_response)
IL (1) IL30258A (enrdf_load_html_response)
LU (1) LU56423A1 (enrdf_load_html_response)
NL (1) NL160723C (enrdf_load_html_response)
SE (2) SE383100B (enrdf_load_html_response)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003792A (en) 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
GB1243832A (en) * 1968-10-25 1971-08-25 Beecham Group Ltd Vaccines
US3957580A (en) * 1974-03-27 1976-05-18 Pfizer Inc. Immobilized microbial cells
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
ATE25708T1 (de) * 1983-06-15 1987-03-15 Gist Brocades Nv Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
ES2098389T3 (es) * 1992-04-25 1997-05-01 Nestle Sa Procedimiento de aromatizacion de un chocolate con leche.
EP0567661A1 (fr) * 1992-04-25 1993-11-03 Societe Des Produits Nestle S.A. Lipase modifiée, procédé de modification et utilisations
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
FR2817870B1 (fr) * 2000-12-08 2006-07-28 Skw Nature Products Holding Fr Polymeres conjugues a base de pectines et leur application comme emulsifiants

Also Published As

Publication number Publication date
SE400652B (sv) 1978-04-03
BE717689A (enrdf_load_html_response) 1968-12-16
DE1768841C3 (de) 1980-09-25
DE1768841B2 (de) 1980-01-31
FR7784M (enrdf_load_html_response) 1970-03-23
GB1174854A (en) 1969-12-17
IL30258A (en) 1972-02-29
CH526590A (de) 1972-08-15
NL160723C (nl) 1979-12-17
SE7511288L (sv) 1975-10-08
NL160723B (nl) 1979-07-16
SE383100B (sv) 1976-03-01
LU56423A1 (enrdf_load_html_response) 1968-10-21
NL6809538A (enrdf_load_html_response) 1969-01-09
FR1584763A (enrdf_load_html_response) 1970-01-02
DE1768841A1 (de) 1971-11-18

Similar Documents

Publication Publication Date Title
ES355853A1 (es) Un procedimiento para preparar un conjugado de un polisaca-rido acido y de una sustancia proteinica bioquimicamente ac-tiva.
US4003792A (en) Conjugates of acid polysaccharides and complex organic substances
Henrici An endotoxin from Aspergillus fumigatus
US20120014991A1 (en) Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US4372883A (en) Process for the production of vaccine
DK0388954T3 (da) Frysetørrede polymerdispersioner og anvendelsen deraf til fremstilling af farmaceutiske præparater m ed langvarig frigivelse
ES2053575T3 (es) Lipasas y extractos lipasicos, su procedimiento de preparacion y su aplicacion en terapeutica.
US5460832A (en) Skin cosmetic having an egg white enzyme hydrolysate with hyaluronic acid synthesis promoting activity
Chetty et al. Soluble peptidoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation
Lambden et al. Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolyasaccharide of Neisseria Gonorrhoeae P9
US3577523A (en) Water-insoluble antigenic substances and method of preparing the same and antigenic depot agents incorporating such substances
ATE98869T1 (de) Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.
Hirsch et al. Specific skin and testis reactions with culture filtrates of Coccidioides immitis
ATE62600T1 (de) Verwendung von pollenextrakten zur herstellung von pharmazeutischen praeparaten zur prophylaktischen behandlung von allergien.
EP0367306A2 (en) Procedure for polymerized allergenis production
DK0421949T3 (da) Kemisk modificerede allergener og fremgangsmåde til deres fremstilling
EP0220453A3 (en) Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same
JP2000507252A (ja) 免疫性物質を産生する方法及びワクチン
GB931016A (en) Amino acids concentrate and intravenous preparations thereof
JPS5634694A (en) Water-soluble cultivation extract of nonpathogenic aerobic corynebacterium having immunological activity, its preparation, and pharmaceutical preparation
Ottaviano et al. Trichophytin extraction: biological comparison of trichophytin extracted from Trichophyton mentagrophytes grown in a complex medium and a defined medium
RU2122862C1 (ru) Бесклеточная антистафилококковая вакцина для лечения хронической стафилококковой инфекции
Peeters et al. Polysaccharicb-conjugate vaccines
Relyveld et al. Preparation of highly immunogenic protein conjugates by direct coupling to glutaraldehyde-treated cells: Comparison with commonly used preparations
SU1580617A1 (ru) Способ получения вакцины против вируса гриппа